rs3212355

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The XM_047435031.1(LOC124903759):​c.1135C>T​(p.Pro379Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.016 in 226,752 control chromosomes in the GnomAD database, including 119 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.022 ( 111 hom., cov: 34)
Exomes 𝑓: 0.0041 ( 8 hom. )

Consequence

LOC124903759
XM_047435031.1 missense

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.166

Publications

10 publications found
Variant links:
Genes affected
MC1R (HGNC:6929): (melanocortin 1 receptor) This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 16-89917970-C-T is Benign according to our data. Variant chr16-89917970-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 321380.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0741 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124903759XM_047435031.1 linkc.1135C>T p.Pro379Ser missense_variant Exon 3 of 4 XP_047290987.1
LOC124903759XM_047435032.1 linkc.*125C>T 3_prime_UTR_variant Exon 3 of 3 XP_047290988.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000267048ENST00000570217.1 linkn.296C>T non_coding_transcript_exon_variant Exon 3 of 3 4
MC1RENST00000555427.1 linkc.-486C>T 5_prime_UTR_variant Exon 2 of 4 5 ENSP00000451760.1 G3V4F0
MC1RENST00000639847.1 linkc.-486C>T 5_prime_UTR_variant Exon 2 of 3 5 ENSP00000492011.1 Q01726

Frequencies

GnomAD3 genomes
AF:
0.0218
AC:
3325
AN:
152252
Hom.:
111
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0764
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00752
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.0119
GnomAD4 exome
AF:
0.00413
AC:
307
AN:
74382
Hom.:
8
Cov.:
0
AF XY:
0.00380
AC XY:
131
AN XY:
34436
show subpopulations
African (AFR)
AF:
0.0723
AC:
245
AN:
3390
American (AMR)
AF:
0.00579
AC:
13
AN:
2244
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4750
East Asian (EAS)
AF:
0.00
AC:
0
AN:
10744
South Asian (SAS)
AF:
0.00
AC:
0
AN:
630
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
70
Middle Eastern (MID)
AF:
0.00222
AC:
1
AN:
450
European-Non Finnish (NFE)
AF:
0.0000871
AC:
4
AN:
45912
Other (OTH)
AF:
0.00711
AC:
44
AN:
6192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0219
AC:
3330
AN:
152370
Hom.:
111
Cov.:
34
AF XY:
0.0216
AC XY:
1611
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.0763
AC:
3174
AN:
41590
American (AMR)
AF:
0.00751
AC:
115
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68040
Other (OTH)
AF:
0.0118
AC:
25
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
151
302
452
603
754
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0176
Hom.:
5
Bravo
AF:
0.0245
Asia WGS
AF:
0.00433
AC:
15
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Melanoma, cutaneous malignant, susceptibility to, 5 Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not provided Benign:1
Mar 24, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.0
DANN
Benign
0.94
PhyloP100
0.17
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3212355; hg19: chr16-89984378; API